Hospital Groups ask Supreme Court to Reverse Ruling that Impacts 340B Eligibility

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.
Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-funded Think Tank Raises Questions About 340B Hospitals’ Charity Care

The Pioneer Institute for Public Policy Research compared 29 financially strong 340B hospitals/health systems’ performance on charity care in an Aug. 19 brief.
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Grants Texas Hospitals’ Request to Temporarily Block DSH Calculation Changes

A federal court sided with a group of Texas hospitals’ efforts to block an HHS rule.
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Raises ‘Serious Concerns’ with MedPAC’s Direction on 340B

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Partially Exempts Missouri, Minnesota Providers from 340B Contract Pharmacy Restrictions

Organon partially exempted covered entities in two states from its contract pharmacy restrictions.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Announces Refunds for 340B Overcharges

GlaxoSmithKline will refund covered entities that purchased certain formulations of a severe asthma treatment in 2022.
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B ESP Updates Claims Submission Policy, Stakeholders Voice Concerns About Compliance

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UPDATED: AbbVie Ends Voluntary 340B Discount Pricing for Dozens of Orphan Drugs

AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.
AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to rural referral centers (RRC), sole [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Seeks Public Comment On ADR Process and Required Administrative Load

HRSA is seeking stakeholder comments on the administrative burden of the updated 340B ADR process.
The Health Resources and Services Administration (HRSA) has requested public comment on how petitioners file their initial claims in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Exempts Maryland, Mississippi from Contract Pharmacy Restrictions

Drugmaker J&J announced for the first time that it is exempting certain states from its 340B contract pharmacy restrictions.
Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live